Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Latest filing published 17 Aug 2026 for Sagimet Biosciences Inc., €134k.
Filing timeline
BuySaleGeorge Kemble
Insider track record
Disclosed buys
0
Disclosed sells
6
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
George Kemble: trading record in brief
All filings by George Kemble on record concern Sagimet Biosciences Inc. We count 12 filings; the first trade dates from 7 September 2023 and the latest from 14 August 2026.
Every open-market trade on record is a sale: 6 sales worth €3.8M. Outside the open market, there are 1 share grant and 5 option exercises. 2026 to date brings no purchases and 3 sales.
The record was last updated on 17 August 2026 with an option exercise (€1.8M) in Sagimet Biosciences Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to George Kemble
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations12 total
24,369 shares@ US$6.360.024% mcap2.3% of flowSeries A Common StockSEC:0001193125-26-354018:1
326,618 shares@ US$6.360.32% mcap30.9% of flowSeries A Common StockSEC:0001193125-26-354018:0
350,987 shares@ US$10.23280.55% mcap53.5% of flowSeries A Common StockSEC:0001193125-26-354018:2
9,751 shares@ US$6.360.010% mcap6.9% of flowSeries A Common StockSEC:0001193125-26-347407:0
10,455 shares@ US$6.360.011% mcap7.5% of flowSeries A Common StockSEC:0001193125-26-347407:1
20,206 shares@ US$9.95480.034% mcap22.5% of flowSeries A Common StockSEC:0001193125-26-347407:2
18,844 shares@ US$7.45750.029% mcap25.2% of flowSeries A Common StockSEC:0001193125-26-312386:0
37,688 shares@ US$7.694269.0% of flowSeries A Common StockSEC:0001104659-25-115071:0
23,625 shares@ US$3.167461.0% of flowSeries A Common StockSEC:0001104659-24-082630:0
14,062 shares@ US$3.100935.4% of flowSeries A Common StockSEC:0001104659-24-081887:0
150,750 shares0Series A Common StockSEC:0001104659-23-120374:0
5,630 shares@ US$0.793.7% of flowSeries A Common StockSEC:0001104659-23-099310:0
12 of 12 declarations
